<DOC>
	<DOCNO>NCT02077946</DOCNO>
	<brief_summary>This trial conduct Europe . The aim study investigate retrospective database assessment clinical effectiveness type 2 diabetes patient treat liraglutide primary care center Sweden .</brief_summary>
	<brief_title>A Retrospective Database Assessment Clinical Effectiveness Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers Sweden</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Patients EMR ( electronic medical record ) system primary care Sweden Patients equal 18 year age Starting treatment liraglutide sitagliptin January 2010 December 2013 Minimum 180 day prior followup/history within database index date Patients cancer , end stage liver disease , end stage renal failure ( nondiabetes relate ) Female patient gestational diabetes pregnancy Patients previous GLP1 ( glucagonlike peptide1 ) DPPIV ( dipeptidyl peptidase4 ) inhibitor use , i.e . patient incretin na√Øve</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>